Romidepsin antagonism with CHOEP

Leukemia. 2023 May;37(5):1160-1161. doi: 10.1038/s41375-023-01873-5. Epub 2023 Mar 11.

Authors

J L Ramdial¹, B C Valdez², B S Andersson², Y Nieto²

Affiliations

¹ Department of Stem Cell Transplantation & Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA. [email protected].
² Department of Stem Cell Transplantation & Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

PMID: 36906714
DOI: 10.1038/s41375-023-01873-5

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols*
Cyclophosphamide
Depsipeptides* / antagonists & inhibitors
Depsipeptides* / pharmacology
Depsipeptides* / therapeutic use
Doxorubicin
Etoposide
Humans
Prednisolone
Vincristine

Substances

Depsipeptides
romidepsin

Supplementary concepts

CHOEP protocol